Login / Signup

Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide.

Julio RosenstockChristopher H SorliMichael E TrautmannCristóbal MoralesUlrich WendischGeorge DaileyMarcus HompeschIn Young ChoiJahoon KangJohn StewartKun-Ho Yoon
Published in: Diabetes care (2019)
Efpeglenatide once weekly led to significant reductions in HbA1c and weight, with a safety profile consistent with the GLP-1 RA class in patients with early T2D mostly on metformin monotherapy.
Keyphrases